Barclays raised the firm’s price target on Pilgrim’s Pride to $35 from $29 and keeps an Overweight rating on the shares following the “solid” Q4 report. Chicken is set to remain the best positioned protein in the U.S and Pilgrim’s sees momentum heading into 2024, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PPC: